HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yayi He Selected Research

OX40 Ligand

1/2021Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment.
8/2019OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers.
1/2019OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yayi He Research Topics

Disease

51Neoplasms (Cancer)
11/2022 - 08/2013
31Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2021 - 01/2013
25Lung Neoplasms (Lung Cancer)
11/2022 - 08/2013
17Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 10/2017
7Adenocarcinoma of Lung
01/2021 - 01/2016
6Neoplasm Metastasis (Metastasis)
06/2021 - 01/2016
5Adenocarcinoma
01/2021 - 01/2016
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2020 - 01/2014
3Infections
11/2022 - 08/2020
3Carcinoma (Carcinomatosis)
01/2021 - 12/2019
2Genomic Instability
10/2021 - 04/2021
2Bites and Stings (Sting)
10/2021 - 01/2020
2Agranulocytosis (Granulocytopenia)
12/2020 - 01/2017
2Diabetes Mellitus
01/2018 - 01/2014
2Lymphoma (Lymphomas)
01/2018 - 01/2017
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Cicatrix (Scar)
10/2021
1Inflammation (Inflammations)
10/2021
1Tuberculosis (Tuberculoses)
10/2021
1Thymoma (Thymic Carcinoma)
08/2021
1Adenoid Cystic Carcinoma (Cylindroma)
07/2021
1Pathologic Constriction (Stenosis)
07/2021
1Airway Obstruction (Choking)
07/2021
1Lymphatic Metastasis
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Breast Neoplasms (Breast Cancer)
12/2020
1Drug-Related Side Effects and Adverse Reactions
12/2020
1Chronic Disease (Chronic Diseases)
10/2020
1Respiratory Tract Infections (Respiratory Tract Infection)
08/2020
1Liver Diseases (Liver Disease)
07/2020
1Hepatitis
07/2020
1Hypoproteinemia
07/2020
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
04/2020

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2013
9Immune Checkpoint InhibitorsIBA
04/2021 - 01/2019
9Tyrosine Kinase InhibitorsIBA
01/2021 - 08/2013
8LigandsIBA
05/2022 - 01/2019
8ErbB Receptors (EGF Receptor)IBA
02/2021 - 08/2013
7Proteins (Proteins, Gene)FDA Link
04/2021 - 12/2016
6Monoclonal AntibodiesIBA
10/2021 - 01/2018
6Pharmaceutical PreparationsIBA
10/2021 - 04/2014
6RNA (Ribonucleic Acid)IBA
01/2021 - 02/2020
5B7-H1 AntigenIBA
10/2021 - 03/2017
5Immunoglobulins (Immunoglobulin)IBA
02/2021 - 01/2018
5HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 01/2017
4Biological ProductsIBA
05/2022 - 01/2020
4MicroRNAs (MicroRNA)IBA
04/2021 - 01/2017
4MucinsIBA
02/2021 - 01/2018
3AntigensIBA
01/2022 - 04/2021
3OX40 LigandIBA
01/2021 - 01/2019
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2020
3Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2016 - 01/2016
2Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 01/2019
2Programmed Cell Death 1 ReceptorIBA
05/2022 - 01/2021
2AutoantibodiesIBA
11/2021 - 01/2018
2InterferonsIBA
10/2021 - 01/2020
2cyclic guanosine monophosphate-adenosine monophosphateIBA
10/2021 - 01/2020
2AntibodiesIBA
08/2021 - 01/2020
2Phosphopyruvate Hydratase (Enolase)IBA
04/2021 - 01/2019
2Therapeutic UsesIBA
02/2021 - 02/2020
2PlatinumIBA
02/2021 - 01/2013
2Small Cytoplasmic RNAIBA
01/2021 - 01/2021
2Antithyroid Agents (Antithyroid Drugs)IBA
12/2020 - 01/2017
2Apoptosis Regulatory ProteinsIBA
12/2019 - 01/2018
2KIR ReceptorsIBA
01/2018 - 12/2016
1geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA
01/2022
1hepsinIBA
01/2022
1delta proteinIBA
01/2022
1Coloring Agents (Dyes)IBA
01/2022
1Mevalonic Acid (Mevalonate)IBA
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1Volatile Organic CompoundsIBA
11/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021
1Monoamine Oxidase (MAO)IBA
07/2021
1Chimeric Antigen ReceptorsIBA
05/2021
1Tumor Biomarkers (Tumor Markers)IBA
04/2021
1Keratin-19 (Keratin 19)IBA
04/2021
1CateninsIBA
04/2021
1Cyclin-Dependent Kinase Inhibitor p16IBA
04/2021
1Phosphotransferases (Kinase)IBA
02/2021
1Formaldehyde (Formol)FDA Link
01/2021
1HLA-DRB6 antigenIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1ParaffinIBA
01/2021
1CholesterolIBA
01/2021
1SolutionsIBA
01/2021
1CytokinesIBA
01/2021
1MethyltransferasesIBA
12/2020
1MutL Protein Homolog 1IBA
12/2020
1MutS ProteinsIBA
12/2020
1micaIBA
12/2020
1BilirubinIBA
07/2020
1EnzymesIBA
07/2020
1Blood Glucose (Blood Sugar)IBA
04/2020

Therapy/Procedure

29Immunotherapy
11/2022 - 09/2016
23Therapeutics
05/2022 - 01/2016
16Drug Therapy (Chemotherapy)
11/2022 - 01/2013
2Islets of Langerhans Transplantation
10/2015 - 01/2014
1Precision Medicine
01/2022
1Radiotherapy
12/2020